SEVEN FLEET CAPITAL MANAGEMENT LP
Q4 2025 Form 13-F
MOUNTAIN VIEW, DELAWARE
CIK 0002092021
· CRD 335203
· SEC-registered investment adviser
Consolidated report · includes
1 manager
since Q4 2025
$147.8M Reported Value Total
SEVEN FLEET CAPITAL MANAGEMENT LP reports 4 total accounts under management (AUM). There are 4 discretionary accounts valued at $434,581,362, and 0 non-discretionary accounts.
Source: Form ADV filed * Note that certain holdings are exempt from Form 13-F reporting, so the AUM totals may be greater than the Form 13-F total.
SEC Registered
Discretionary Manager
Private funds (Form ADV)
2 funds
· $434.6M gross asset value
Hedge Fund: $263.1M · Other: $171.4M
Source: Form ADV filed 2026-07-06
Reported value
$147.8M
Quarter over quarter
0.0%
Holdings
85
Top-10 concentration
68.4%
Filing Structure
Reports holdings for
- DV Trading LLC · File #028-26555 · since Q4 2025 · declared by one filing
Key People
Form ADV owners & control persons
Brian Guan-Chyun Liu
MANAGING MEMBER
Rod Seung-Hwan Lim
LIMITED PARTNER OF SEVEN FLEET MANAGEMENT LP
Filing Navigation
13F Metrics
Loading 13F Metrics
Q4 2025 13F record
Q4 2025 13F filing summary
| Period of report | December 31, 2025 |
|---|---|
| Filed | February 26, 2026 |
| Form | 13F-HR |
| Reported value | $147.8M |
| Positions | 85 |
| Change in reported value | First reported quarter |
| Top-10 concentration | 68.4% |
13F filings by quarter
| Quarter | Positions | Value |
|---|---|---|
|
Q2 2026 13F
Filed Aug 15, 2026
|
96 | $605.9M |
|
Q1 2026 13F
Filed May 15, 2026
|
115 | $318.3M |
|
Q4 2025 13F
Filed Feb 26, 2026
|
85 | $147.8M |
Top 20 holdings · Q4 2025
| # | Holding | Reported value | % of portfolio |
|---|---|---|---|
| 1 | CGON CG ONCOLOGY INC | $62.9M | 42.57% |
| 2 | COGT COGENT BIOSCIENCES INC | $7.6M | 5.15% |
| 3 | SLNO SOLENO THERAPEUTICS INC | $6.0M | 4.08% |
| 4 | TERN TERNS PHARMACEUTICALS INC | $5.3M | 3.57% |
| 5 | RVMD REVOLUTION MEDICINES INC | $5.2M | 3.55% |
| 6 | LQDA LIQUIDIA CORPORATION | $3.1M | 2.13% |
| 7 | CMPX COMPASS THERAPEUTICS INC | $3.1M | 2.07% |
| 8 | EXEL EXELIXIS INC | $3.0M | 2.03% |
| 9 | ASMB ASSEMBLY BIOSCIENCES INC | $2.5M | 1.7% |
| 10 | AXSM AXSOME THERAPEUTICS INC | $2.4M | 1.6% |
| 11 | TYRA TYRA BIOSCIENCES INC | $2.1M | 1.42% |
| 12 | TNGX TANGO THERAPEUTICS INC | $1.9M | 1.29% |
| 13 | ABVX ABIVAX SA | $1.8M | 1.23% |
| 14 | XNCR XENCOR INC | $1.7M | 1.14% |
| 15 | ELVN ENLIVEN THERAPEUTICS INC | $1.5M | 1.04% |
| 16 | PHVS PHARVARIS N V | $1.5M | 1.04% |
| 17 | MLYS MINERALYS THERAPEUTICS INC | $1.5M | 1.03% |
| 18 | BLTE BELITE BIO INC | $1.5M | 0.99% |
| 19 | DYN DYNE THERAPEUTICS INC | $1.4M | 0.93% |
| 20 | NUVL NUVALENT INC | $1.3M | 0.86% |
Values as reported on the Q4 2025 Form 13F. Every position is in the holdings table below.